The Role of Split-course Hypofractionated Palliative Radiotherapy in Head and Neck Cancer
- 31 March 2011
- journal article
- research article
- Published by Elsevier BV in Clinical Oncology
- Vol. 23 (2), 141-148
- https://doi.org/10.1016/j.clon.2010.09.006
Abstract
No abstract availableThis publication has 25 references indexed in Scilit:
- Radiochemotherapy in Locally Advanced Squamous Cell Carcinomas of the Head and NeckClinical Oncology, 2009
- Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): An update on 93 randomised trials and 17,346 patientsRadiotherapy and Oncology, 2009
- Hypofractionated, palliative radiotherapy for advanced head and neck cancerRadiotherapy and Oncology, 2008
- Hyperfractionated or accelerated radiotherapy in head and neck cancer: a meta-analysisThe Lancet, 2006
- Radiotherapy plus Cetuximab for Squamous-Cell Carcinoma of the Head and NeckThe New England Journal of Medicine, 2006
- The ‘QUAD SHOT’—a phase II study of palliative radiotherapy for incurable head and neck cancerRadiotherapy and Oncology, 2005
- Short course palliative radiotherapy of 20Gy in 5 fractions for advanced and incurable head and neck cancer: AIIMS studyRadiotherapy and Oncology, 2004
- Combined radiotherapy and bleomycin in patients with inoperable head and neck cancer with unfavourable prognostic factors and severe symptomsOral Oncology, 1998
- Treatment of Patients with Stage IV Cancer: Do the Ends Justify the Means?Otolaryngology -- Head and Neck Surgery, 1987
- Randomized trial of conventional versus high fractional dose radiation therapy in the treatment of advanced head and neck cancerInternational Journal of Radiation Oncology*Biology*Physics, 1982